PRUCALOPRIDE MEDSURGE prucalopride (as succinate) 1 mg tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

prucalopride succinate, Quantity: 1.321 mg (Equivalent: prucalopride, Qty 1 mg)

Tilgjengelig fra:

Medsurge Pharma Pty Ltd

Legemiddelform:

Tablet

Sammensetning:

Excipient Ingredients: titanium dioxide; lactose monohydrate; macrogol 400; colloidal anhydrous silica; magnesium stearate; hypromellose; polysorbate 80; microcrystalline cellulose

Administreringsrute:

Oral

Enheter i pakken:

28 tablets

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief.,? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation.,? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Produkt oppsummering:

Visual Identification: White to off-white, circular, film coated tablet with 'C' debossed on one side and '11' on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorisasjon status:

Registered

Autorisasjon dato:

2022-02-04